Peptides
5-Amino-1MQ
5-Amino-1MQ is a small-molecule NNMT inhibitor widely discussed in metabolic and fat-loss research. Below, we compare vendors currently stocking research-grade 5-Amino-1MQ — not just a single sales page.
5-Amino-1MQ is a small-molecule NNMT inhibitor widely discussed in metabolic and fat-loss research. Below, we compare vendors currently stocking research-grade 5-Amino-1MQ — not just a single sales page.
Prices and testing claims are pulled from each vendor's product listing. Always confirm current price and COA (Certificate of Analysis) on the vendor's site before buying.
| Vendor | Price | Purity Testing | Code | |
|---|---|---|---|---|
 MuscleChemBest Value |
£24.99 | In-house testing | Buy Here → | |
 American Peptides |
$80.00 | Third-party COA | Buy Here → | |
 Chemyo |
$109.99 (30mg/ml solution) | Third-party COA | Buy Here → |
5-Amino-1MQ is a small-molecule compound studied as a selective inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme involved in cellular energy metabolism. It is a small molecule rather than a peptide, but is frequently sold and researched alongside metabolic peptides.
Research-grade 5-Amino-1MQ is typically supplied as capsules or a lyophilized powder, commonly at 50mg per capsule, intended for laboratory research use only.
5-Amino-1MQ inhibits NNMT, an enzyme that regulates NAD+ and SAM (S-adenosylmethionine) levels within cells; researchers have proposed that this inhibition shifts cellular energy metabolism toward increased fat-cell metabolism and away from fat storage.
Preclinical rodent studies have investigated 5-Amino-1MQ's effects on fat-cell size and body composition, positioning NNMT inhibition as a novel target distinct from incretin-based (GLP-1) approaches to metabolic research.
Because NNMT activity is tied to cellular NAD+ availability, 5-Amino-1MQ is also studied within the broader NAD+/cellular-energy research space that overlaps with aging and mitochondrial-function research.
5-Amino-1MQ is an early-stage research compound with a published record limited mostly to preclinical rodent studies. It has not been evaluated in human clinical trials, is not FDA-approved, and comprehensive human safety data does not exist.
Doses used in preclinical rodent studies are documented in that specific research and do not translate to an established human dose. No human dosage of any kind has been clinically validated for 5-Amino-1MQ.
Compound X does not sell 5-Amino-1MQ directly. We provide independent research, comparisons and vendor links — see the vendor comparison table above for current US, UK, Canada and Australia options.
5-Amino-1MQ research is indexed on PubMed under search terms such as "5-amino-1MQ NNMT inhibitor" and "nicotinamide N-methyltransferase adipose."
New guides, vendor comparisons and compound breakdowns every week.